Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
CSL Behring calls for grant requests through LEAD program

CSL Behring calls for grant requests through LEAD program

Parents lack understanding of causes, signs and symptoms of dehydration in children

Parents lack understanding of causes, signs and symptoms of dehydration in children

FDA approves TachoSil adjunctive hemostatic agent for use in cardiovascular surgery

FDA approves TachoSil adjunctive hemostatic agent for use in cardiovascular surgery

NYBC urges community to donate blood and save lives

NYBC urges community to donate blood and save lives

DSMB for DIGNITY trial recommends Celsion continue enrollment

DSMB for DIGNITY trial recommends Celsion continue enrollment

Plant-based system could help improve lives of hemophilic patients

Plant-based system could help improve lives of hemophilic patients

Patients switching to Victoza experience further reductions in A1c and weight loss

Patients switching to Victoza experience further reductions in A1c and weight loss

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Novo Nordisk BlueSheet launched to provide information on diabetes and chronic disease

Single dose of Pain Therapeutics' PTI-188 decreased  melanoma tumors: Study

Single dose of Pain Therapeutics' PTI-188 decreased melanoma tumors: Study

NYBC joins "Honor Roll of Life" of US blood centers to support Haiti relief effort

NYBC joins "Honor Roll of Life" of US blood centers to support Haiti relief effort

Novo Nordisk awarded funds to support diabetes summer camps nationwide

Novo Nordisk awarded funds to support diabetes summer camps nationwide

GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009

GTC Biotherapeutics reports total net loss of $1.7M for fourth-quarter 2009

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

Growing incidence of chronic kidney disease: Early detection and knowledge of treatment options vital

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Senators to FDA: Lift ban on gays donating blood

Senators to FDA: Lift ban on gays donating blood

Recipients for 2010 Scholar Awards announced

Recipients for 2010 Scholar Awards announced

FDA approves CSL Behring's Hizentra for PI

FDA approves CSL Behring's Hizentra for PI

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Gene therapy for LCA clears another hurdle: Study

Gene therapy for LCA clears another hurdle: Study